Institution Directory

Clinical trials at Stanford Medicine

Sites in Stanford & Palo Alto, CA

Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.

ClinicalTrials.gov public records Last synced Oct 14, 2026, 4:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

1365

Shown on this page

Current sort

Stored official records

Conditions: Parathyroid Adenoma
Interventions: 18Fluorocholine; Drug
Lead sponsor: Andrei Iagaru; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Stanford, California

Conditions: Epstein-Barr Virus Related Carcinoma, Nasopharyngeal Cancer
Interventions: VK-2019; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: ASD, Autism, Autism Spectrum Disorder
Interventions: Center-Based Pivotal Response Treatment (PRT) Intervention (PRT-C), Home-Based Pivotal Response Treatment (PRT Intervention (PRT-H); Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 2 Years to 5 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Stanford, California

Conditions: Acute Lymphoblastic Leukemia
Interventions: Asparaginase Erwinia Chrysanthemi, Bortezomib, Cyclophosphamide, Cytarabine, Dexamethasone, Etoposide, ITMHA, Leucovorin Calcium, Mercaptopurine, Methotrexate, Mitoxantrone, Pegaspargase, Vincristine, Vorinostat; Drug
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Up to 365 Days
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2031
U.S. locations: 9
States / cities: Los Angeles, California • Orange, California • Palo Alto, California + 6 more

Conditions: Severe Aortic Stenosis
Interventions: Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI), Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI), Surgical Aortic Valve Replacement (SAVR); Device · Procedure
Lead sponsor: Medtronic Cardiovascular; Industry
Eligibility: Not listed
Enrollment: 1,746 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2026
U.S. locations: 65
States / cities: Phoenix, Arizona • Hollywood, California • La Jolla, California + 55 more

Conditions: Carcinoma, Non-Small-Cell Lung, Endometrial Neoplasms, Neoplasm Metastasis, Small Cell Lung Carcinoma, Triple Negative Breast Cancer
Interventions: Carboplatin, Cisplatin, LY4175408, Pembrolizumab; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 15
States / cities: Stanford, California • Orlando, Florida • Sarasota, Florida + 11 more

Conditions: Major Depression, Sleep
Interventions: TMS; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Stanford, California

Conditions: Nasopharyngeal Carcinoma
Interventions: Concurrent Chemoradiation and Adjuvant treatment following Chemoradiation, Toripalimab; Radiation · Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndromes
Interventions: ORCA-T; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Osteoarthritis, Knee
Interventions: Gait retraining; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Aortic Stenosis
Interventions: Matching placebo, Pelacarsen (TQJ230) 80mg; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 50 Years to 80 Years
Enrollment: 502 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 35
States / cities: Huntsville, Alabama • Beverly Hills, California • Covina, California + 26 more

Conditions: Autism Spectrum Disorder
Interventions: Pivotal Response Treatment; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 2 Years to 5 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Palo Alto, California

About this Stanford Medicine institution page

What this page lists: ClinicalTrials.gov records that list Stanford Medicine in Stanford & Palo Alto, CA as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status: A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.

Clinical trials at Stanford Medicine

Filter and sort this campus

Stored official records

99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT

Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies

Trial of Center-Based vs. In-Home Pivotal Response Treatment (PRT) in Autism

Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).

A Study of LY4175408 in Participants With Advanced Cancer

Sleep TMS for Depression

Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC)

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

Effects of Movement Retraining on Knee Loading in Individuals With Knee Osteoarthritis

A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

Trial of an Online Spanish Pivotal Response Treatment Training in Autism Spectrum Disorder

About this Stanford Medicine institution page